A carregar...
Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups
Following the success of immune checkpoint blockers (ICBs) in different cancer types, a large number of studies are currently investigating ICBs in patients with hepatocellular carcinoma (HCC), alone or in combination with other treatments. Both nivolumab and pembrolizumab, as well as the combinatio...
Na minha lista:
| Publicado no: | Gut |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7788203/ https://ncbi.nlm.nih.gov/pubmed/32747413 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gutjnl-2020-321702 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|